Magnesium Sulphate Ethypharm

Magnesium sulfate, the active ingredient in Magnesium Sulphate Ethypharm, is an electrolyte (magnesium salt) presented as an injection solution for intramuscular and intravenous use. It is employed to prevent and treat eclampsia, correct magnesium deficiency, manage certain ventricular arrhythmias and assist in severe asthma exacerbations.

GNH USA supplies Magnesium Sulphate Ethypharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium Sulfate is used across several clinical pathways involving electrolyte balance and neuromuscular control.

- Pre‑eclampsia/eclampsia: prevention and treatment of seizures in pregnant women with severe pre‑eclampsia or eclampsia. - Magnesium deficiency: rapid repletion of low serum magnesium levels. - Ventricular arrhythmias: control of torsades de pointes and other life‑threatening ventricular rhythms. - Severe asthma: adjunct therapy to relax bronchial smooth muscle during acute exacerbations.

Adverse reactions may vary with dose, route and patient condition.

Common Side Effects: - Flushing or warmth at the injection site - Sweating and feeling of heat - Nausea or mild vomiting - Hypotension or transient blood pressure drop - Muscle weakness or fatigue - Headache

Serious or Rare Side Effects: - Respiratory depression or arrest - Severe hypotension leading to shock - Cardiac arrhythmias or cardiac arrest - Hypermagnesemia with neuromuscular blockade - Anaphylactic or severe allergic reactions - Local tissue necrosis if extravasation occurs

Magnesium Sulfate requires careful monitoring in specific clinical situations. - Assess renal function: avoid or adjust in severe renal impairment due to reduced clearance. - Monitor serum magnesium: maintain therapeutic range to prevent toxicity. - Evaluate cardiac status: watch for bradycardia or conduction abnormalities. - Use cautiously in patients with myasthenia gravis or other neuromuscular disorders. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium Sulfate can alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Neuromuscular blocking agents (e.g., succinylcholine, non‑depolarizing blockers): may cause prolonged paralysis. - Calcium channel blockers: additive hypotensive effect. - Other magnesium‑containing products: risk of hypermagnesemia. - Aminoglycoside antibiotics: enhanced neuromuscular blockade. - Potassium‑sparing diuretics: may increase serum magnesium levels.

Moderate Interactions (Monitor Closely): - Loop and thiazide diuretics: can affect magnesium balance. - ACE inhibitors or ARBs: monitor blood pressure and renal function. - Digoxin: watch for altered cardiac conduction. - Anticoagulants: potential for altered clotting parameters. - Certain anti‑epileptic drugs: may require dose adjustment.